BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 224356)

  • 1. Cell-mediated immunity in patients with cervical cancer.
    Cerni C; Tatra G; Berger R; Micksche M
    Oncology; 1979; 36(4):164-70. PubMed ID: 224356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
    Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
    Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitization of lymphocyte to tumor extract detected by macrophage migration inhibition test(MIT) in patients with cervical cancer (author's transl)].
    Ohno M
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jul; 32(7):919-28. PubMed ID: 7240870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
    Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations on general immune reactivity in untreated cervical cancer patients.
    Micksche M; Luger T; Michalica W; Tatra G
    Oncology; 1978; 35(5):206-9. PubMed ID: 724199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative diagnostic aspects of herpes simplex virus tumor-associated antigens.
    Notter MF; Docherty JJ
    J Natl Cancer Inst; 1976 Sep; 57(3):483-8. PubMed ID: 185398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular hypersensitivity in patients with adenomatous hyperplasia and adenocarcinoma of the endometrium.
    Chen SY; Cohen CJ; Koffler D
    Am J Obstet Gynecol; 1976 Oct; 126(3):370-3. PubMed ID: 986771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated antigens in cervical cancer tissues and in sera from patients with cervical cancer or with head and neck cancer.
    Ibrahim AN; Robinson RA; Marr L; Abdelal AT; Nahmias AJ
    J Natl Cancer Inst; 1979 Aug; 63(2):319-23. PubMed ID: 88537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
    Notter MF; Docherty JJ
    Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Skin tests as immunologic parameters in cervical cancer].
    Wagner G
    Wien Klin Wochenschr; 1984 Jun; 96(12):467-73. PubMed ID: 6475075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leukocyte migration inhibition assay of tumor immunity in patients with cervical squamous cell carcinoma.
    Rivera ES; Hersh EM; Bowen JM; Barnett JW; Wharton T; Murphy SG
    Cancer; 1979 Jun; 43(6):2297-305. PubMed ID: 455220
    [No Abstract]   [Full Text] [Related]  

  • 12. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune reactivity in primary carcinoma of the lung and its relation to prognosis.
    Wanebo HJ; Rao B; Miyazawa N; Martini N; Middleman MP; Oettgen HF; Beattie EJ
    J Thorac Cardiovasc Surg; 1976 Sep; 72(3):339-50. PubMed ID: 183063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Cell mediated response to herpes simplex virion and non-virion antigens in patients with cervical carcinoma with a depressed response to phytohemagglutinin.
    Sprecher-Golberger S; Thiry L; de Halleux F; Bossens M; Gould I
    Biomedicine; 1975 Nov; 23(9):399-401. PubMed ID: 182294
    [No Abstract]   [Full Text] [Related]  

  • 15. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
    Kokoschka EM; Cerni C; Micksche M
    Oncology; 1977; 34(5):229-33. PubMed ID: 917456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue: five case studies.
    Notter MF; Docherty JJ; Mortel R; Hollinshead AC
    Gynecol Oncol; 1978 Dec; 6(6):574-81. PubMed ID: 220150
    [No Abstract]   [Full Text] [Related]  

  • 17. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
    Lee YT; Sparks FC; Eilber FR; Morton DL
    Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of immunology in the diagnosis, prognosis and treatment planning of oral cancer.
    Shillitoe EJ
    Proc R Soc Med; 1976 Oct; 69(10):747-9. PubMed ID: 186794
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on immunospecificity of skin test using tumor extract in gynecological malignancy (author's transl)].
    Yuzawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):611-8. PubMed ID: 6165790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune evaluation of lung cancer patients undergoing radiation therapy.
    Stefani S; Kerman R; Abbate J
    Cancer; 1976 Jun; 37(6):2792-6. PubMed ID: 181124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.